Literature DB >> 19494301

A single nucleotide polymorphism in Tyk2 controls susceptibility to experimental allergic encephalomyelitis.

Karen M Spach1, Rajkumar Noubade, Ben McElvany, William F Hickey, Elizabeth P Blankenhorn, Cory Teuscher.   

Abstract

Genes controlling immunopathologic diseases of differing etiopathology may also influence susceptibility to autoimmune disease. B10.D1-H2(q)/SgJ mice with a 2538 G-->A missense mutation in the tyrosine kinase-2 gene (Tyk2) are susceptible to Toxoplasma gondii yet resistant to autoimmune arthritis, unlike the wild-type B10.Q/Ai substrain. To understand whether Tyk2 is also important in a second autoimmune model, experimental allergic encephalomyelitis (EAE) was induced in B10.D1-H2(q)/SgJ (Tyk2(A)) and B10.Q/Ai (Tyk2(G)) mice with the myelin oligodendrocyte glycoprotein peptide 79-96. B10.D1-H2(q)/SgJ mice were resistant to EAE whereas B10.Q/Ai mice were susceptible, and a single copy of the Tyk2(G) allele conferred EAE susceptibility in F(1) hybrids. Furthermore, EAE resistance in B10.D1-H2(q)/SgJ mice was overridden when pertussis toxin (PTX) was used to mimic the effects of environmental factors derived from infectious agents. Numerous cytokines and chemokines were increased when PTX was included in the immunization protocol. However, only RANTES, IL-6, and IFN-gamma increased significantly with both genetic compensation and PTX treatment. These data indicate that Tyk2 is a shared autoimmune disease susceptibility gene whose genetic contribution to disease susceptibility can be modified by environmental factors. Single nucleotide polymorphisms like the one that distinguishes Tyk2 alleles are of considerable significance given the potential role of gene-by-environment interactions in autoimmune disease susceptibility.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19494301      PMCID: PMC3008628          DOI: 10.4049/jimmunol.0900142

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  82 in total

1.  TCR-mediated hyper-responsiveness of autoimmune Galphai2(-/-) mice is an intrinsic naïve CD4(+) T cell disorder selective for the Galphai2 subunit.

Authors:  Tiffany T Huang; Yumei Zong; Harnisha Dalwadi; Chan Chung; M Carrie Miceli; Karsten Spicher; Lutz Birnbaumer; Jonathan Braun; Richard Aranda
Journal:  Int Immunol       Date:  2003-11       Impact factor: 4.823

2.  Cell-surface bound pertussis toxin induces polyclonal T cell responses with high levels of interferon-gamma in the absence of interleukin-12.

Authors:  Ayako Wakatsuki; Persephone Borrow; Kevin Rigley; Peter C L Beverley
Journal:  Eur J Immunol       Date:  2003-07       Impact factor: 5.532

3.  Co-occurrence of celiac disease and other autoimmune diseases in celiacs and their first-degree relatives.

Authors:  Susan L Neuhausen; Linda Steele; Sarah Ryan; Maryam Mousavi; Marie Pinto; Kathryn E Osann; Pamela Flodman; John J Zone
Journal:  J Autoimmun       Date:  2008-08-08       Impact factor: 7.094

Review 4.  The use of chemokine antagonists in EAE models.

Authors:  Amanda E I Proudfoot; Adriano Luís Soares de Souza; Valeria Muzio
Journal:  J Neuroimmunol       Date:  2008-06-11       Impact factor: 3.478

5.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain.

Authors:  Daniel J Cua; Jonathan Sherlock; Yi Chen; Craig A Murphy; Barbara Joyce; Brian Seymour; Linda Lucian; Wayne To; Sylvia Kwan; Tatyana Churakova; Sandra Zurawski; Maria Wiekowski; Sergio A Lira; Daniel Gorman; Robert A Kastelein; Jonathon D Sedgwick
Journal:  Nature       Date:  2003-02-13       Impact factor: 49.962

6.  SNPs upstream of the minimal promoter control IL-2 expression and are candidates for the autoimmune disease-susceptibility locus Aod2/Idd3/Eae3.

Authors:  R del Rio; R Noubade; M Subramanian; N Saligrama; S Diehl; M Rincon; C Teuscher
Journal:  Genes Immun       Date:  2008-01-17       Impact factor: 2.676

7.  A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunity.

Authors:  Michael H Shaw; Victor Boyartchuk; Sandy Wong; Marina Karaghiosoff; Josiane Ragimbeau; Sandra Pellegrini; Mathias Muller; William F Dietrich; George S Yap
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-18       Impact factor: 11.205

8.  Early identification of interferon-beta responders by ex vivo testing in patients with multiple sclerosis.

Authors:  Elke Wiesemann; Milani Deb; Bernhard Hemmer; Heinfried H Radeke; Anja Windhagen
Journal:  Clin Immunol       Date:  2008-06-09       Impact factor: 3.969

9.  T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis.

Authors:  Chris J Hedegaard; Martin Krakauer; Klaus Bendtzen; Henrik Lund; Finn Sellebjerg; Claus H Nielsen
Journal:  Immunology       Date:  2008-04-04       Impact factor: 7.397

10.  Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study.

Authors:  I A F van der Mei; A-L Ponsonby; T Dwyer; L Blizzard; R Simmons; B V Taylor; H Butzkueven; T Kilpatrick
Journal:  BMJ       Date:  2003-08-09
View more
  20 in total

Review 1.  Tyrosine kinases in inflammatory dermatologic disease.

Authors:  Ricardo T Paniagua; David F Fiorentino; Lorinda Chung; William H Robinson
Journal:  J Am Acad Dermatol       Date:  2010-06-26       Impact factor: 11.527

2.  Inhibition of TYK2 and JAK1 ameliorates imiquimod-induced psoriasis-like dermatitis by inhibiting IL-22 and the IL-23/IL-17 axis.

Authors:  Melissa G Works; Fangfang Yin; Catherine C Yin; Ying Yiu; Kenneth Shew; Thanh-Thuy Tran; Nahoko Dunlap; Jennifer Lam; Tim Mitchell; John Reader; Paul L Stein; Annalisa D'Andrea
Journal:  J Immunol       Date:  2014-08-25       Impact factor: 5.422

3.  Sex-specific control of central nervous system autoimmunity by p38 mitogen-activated protein kinase signaling in myeloid cells.

Authors:  Dimitry N Krementsov; Rajkumar Noubade; Julie A Dragon; Kinya Otsu; Mercedes Rincon; Cory Teuscher
Journal:  Ann Neurol       Date:  2014-01       Impact factor: 10.422

Review 4.  Impact of microbes on autoimmune diseases.

Authors:  Claudia Danzer; Jochen Mattner
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-02-16       Impact factor: 4.291

Review 5.  IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases.

Authors:  Hao Li; George C Tsokos
Journal:  Clin Rev Allergy Immunol       Date:  2020-11-13       Impact factor: 8.667

6.  Genetics of experimental allergic encephalomyelitis supports the role of T helper cells in multiple sclerosis pathogenesis.

Authors:  Elizabeth P Blankenhorn; Russell Butterfield; Laure K Case; Emma H Wall; Roxana del Rio; Sean A Diehl; Dimitry N Krementsov; Naresha Saligrama; Cory Teuscher
Journal:  Ann Neurol       Date:  2011-12       Impact factor: 10.422

7.  Modeling month-season of birth as a risk factor in mouse models of chronic disease: from multiple sclerosis to autoimmune encephalomyelitis.

Authors:  Jacob D Reynolds; Laure K Case; Dimitry N Krementsov; Abbas Raza; Rose Bartiss; Cory Teuscher
Journal:  FASEB J       Date:  2017-03-14       Impact factor: 5.191

8.  Exacerbation of autoimmune neuroinflammation by dietary sodium is genetically controlled and sex specific.

Authors:  Dimitry N Krementsov; Laure K Case; William F Hickey; Cory Teuscher
Journal:  FASEB J       Date:  2015-04-27       Impact factor: 5.191

9.  Allelic variation in the Tyk2 and EGF genes as potential genetic determinants of CNS repair.

Authors:  Allan J Bieber; Kanitta Suwansrinon; Jason Kerkvliet; Weidong Zhang; Larry R Pease; Moses Rodriguez
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

10.  The postnatal maternal environment affects autoimmune disease susceptibility in A/J mice.

Authors:  Laure K Case; Roxana Del Rio; Elizabeth A Bonney; James F Zachary; Elizabeth P Blankenhorn; Kenneth S K Tung; Cory Teuscher
Journal:  Cell Immunol       Date:  2010       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.